Announcements Trials
Browse Landscape

Phase

Phase 3 11Phase NA 4Phase 4 4Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Classical hematology 1

Conditions

Venous Thromboembolism 2Thrombosis 2Thrombocytopenia 2Primary Myelofibrosis 2Lymphoma 2Anemia, Aplastic 2Venous Thrombosis 1Thromboembolism 1Thrombocytosis 1Pulmonary Embolism 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Genetic Diseases, Inborn 1Cytopenia 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Anemia, Hemolytic, Autoimmune 1Anemia 1

Interventions

apixaban 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Pulmonary Embolism × Classical hematology × Clear all
NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡